You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Pioneering Breakthroughs in Mental Health Treatment

Occentis is a drug discovery and development company, focusing on mental health, with a groundbreaking approach backed by over two decades of extensive research conducted at the renowned French National Center for Scientific Research (CNRS) under the guidance of Professor Marcel Hibert, a distinguished figure in medicinal chemistry. Our mission is to revolutionise the treatment landscape for neuropsychiatric and neurobehavioral conditions, addressing significant unmet needs in therapeutic areas such as Autism, Alcohol and Opioid addiction, Pain and other conditions. In close collaboration with Conectus, a leading technology transfer and innovation organization working with the CNRS, Occentis has exclusively licensed this remarkable research. Conectus, known for its expertise in bridging the gap between academia and industry, played a pivotal role in this partnership. Together with the CNRS and Professor HIBERT, Occentis is aiming to address critical unmet needs in mental health.

Our strengths

Clear Strategy

Our strategic approach revolves around the development of novel drugs and establishing strategic partnerships with pharmaceutical companies for the final stages of development and commercialisation.

Pioneering Novelty

With our strong commitment to pioneering innovation, we stand at the forefront of drug discovery, armed with the groundbreaking technology that has the potential to redefine mental health treatment.

Blockbuster Potential

With the innovative science and building on over two decades of research at the CNRS, we are committed to offer truly transformative therapies with blockbuster sales potential, making Occentis a leading player in the sector.

Contact us

Leading the Way

Our Vision & Values

Our vision is to become a pioneering biotech company, developing disruptive treatments to improve the health of millions of people worldwide. We achieve this vision by upholding a set of values that are core to our company.

Innovation & Creativity, Integrity & Commitment, Diversity & Inclusion, Passion & Professionalism and Value & Fairness.

Power of Collaboration: Accelerating Development

In the dynamic landscape of the pharmaceutical industry, collaborations play a vital role in driving innovation and bringing transformative therapies to patients. Occentis embraces a collaborative approach to drug development. We recognise that approximately 30-40% of drugs in the pipelines of major pharmaceutical companies are licensed from biotech counterparts. Our long experience in the pharma industry allows us to navigate the complexities of drug development, maximise success rates, and deliver life-changing treatments to people suffering from mental health conditions.

Neuropsychiatric, Autism Spectrum Disorder (ASD), Neurobehavioral, Prader-Willi Syndrome (PWS), Emotion Regulation, Post-Traumatic Stress Disorder (PTSD), Social Cognition, Alcohol Use Disorder (AUD), Neurodevelopmental, Generalized Anxiety Disorder (GAD), Pain, Neuropathic Pain, new drugs

Leadership & Management

Team

Occentis is managed and supported by a highly experienced Board of Directors, Scientific Advisory Board and Management Team, with each member typically having over 30 years' experience in its field of expertise.

More soon
drug development company- new drugs

The meaning behind our name

Occentis carries a profound narrative rooted in the remarkable influence of oxytocin on human well-being. Our name is a fusion of 'Oxytocin' and 'Centis,' symbolising the core of compassion and emotional balance. Oxytocin, often referred to as the 'love hormone,' plays a pivotal role in bonding, trust, and emotional resilience. Similarly, Occentis embodies our dedication to advancing mental health by harnessing the potential of oxytocin. Just as oxytocin fosters meaningful human connections, we aspire to pioneer therapies that offer hope for individuals facing mental health challenges. Occentis reflects our relentless commitment to enriching lives and shaping the future of mental health treatments.